Company leaders say the Covid-19 pandemic is still complicating patient treatment patterns
Click here to view original post
Related Articles
Zynex Submits FDA Application for Its NiCO Laser Pulse Oximeter
ENGLEWOOD, Colo., May 12, 2025 /PRNewswire/ — Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced […]
Medtronic partners with CU campuses to develop future medical technology
The medical device giant is putting an initial $250,000 toward innovation at University of Colorado campuses. Click here to view original post Click Here to Publish/Feature Your Company or Product News with Biotech Networks
Edgewise Receives U.S. FDA Fast Track Designation for EDG-5506 for the Treatment of Duchenne Muscular Dystrophy (Duchenne)
BOULDER, Colo.–(BUSINESS WIRE)–Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for EDG-5506 for the treatment of Duchenne. […]
